These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6200439)

  • 21. [The isolation and purification of a staphylococcal exotoxin in toxic shock and the production of antisera].
    Tekut'ev SI
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):105-6. PubMed ID: 7879494
    [No Abstract]   [Full Text] [Related]  

  • 22. Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.
    Schlievert PM
    Infect Immun; 1982 Apr; 36(1):123-8. PubMed ID: 7042568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci.
    Schlievert PM
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3056-62. PubMed ID: 17576832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic shock syndrome: modification and comparison of methods for detecting marker proteins in Staphylococcus aureus.
    Cohen ML; Graves LM; Hayes PS; Gibson RJ; Rasheed JK; Feeley JC
    J Clin Microbiol; 1983 Aug; 18(2):372-5. PubMed ID: 6619287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preparation and properties of the staphylococcal toxin causing the toxic shock syndrome].
    Fan'kovskaia MK; Ezepchuk IuV; Solov'eva MN; Shcheglovitova ON
    Mol Gen Mikrobiol Virusol; 1987 Jul; (7):23-7. PubMed ID: 3670320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatographic separation and characterization of Pasteurella haemolytica cytotoxin.
    Mosier DA; Lessley BA; Confer AW; Antone SM; Gentry MJ
    Am J Vet Res; 1986 Oct; 47(10):2233-41. PubMed ID: 3096174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
    Bonventre PF; Heeg H; Cullen C; Lian CJ
    Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen.
    McCormick JK; Pragman AA; Stolpa JC; Leung DY; Schlievert PM
    Infect Immun; 2001 Mar; 69(3):1381-8. PubMed ID: 11179302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and purity assessment of toxic shock syndrome toxin 1.
    Rosten PM; Bartlett KH; Chow AW
    Rev Infect Dis; 1989; 11 Suppl 1():S110-5; discussion S115-6. PubMed ID: 2494689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A rapid method of detecting the staphylococcal exotoxin of toxic shock].
    Fluer FS; Pozhar PF; Ratgauz GL; Akatov AK
    Lab Delo; 1989; (4):62-4. PubMed ID: 2470975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model.
    de Azavedo JC; Foster TJ; Hartigan PJ; Arbuthnott JP; O'Reilly M; Kreiswirth BN; Novick RP
    Infect Immun; 1985 Oct; 50(1):304-9. PubMed ID: 4044040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
    De Boer ML; Kum WW; Chow AW
    Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isolation and characterization of erythrogenic toxins. VII. Study of the erythrogenic toxin type C produced by Streptococcus pyogenes].
    Ozegowski JH; Knöll H; Gerlach D; Köhler W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):38-50. PubMed ID: 6431714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Group A streptococcal phage T12 carries the structural gene for pyrogenic exotoxin type A.
    Johnson LP; Schlievert PM
    Mol Gen Genet; 1984; 194(1-2):52-6. PubMed ID: 6374381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of alpha-toxin from Staphylococcus aureus and application to cell permeabilization.
    Lind I; Ahnert-Hilger G; Fuchs G; Gratzl M
    Anal Biochem; 1987 Jul; 164(1):84-9. PubMed ID: 3674374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural phosphorylation of group A streptococcal pyrogenic exotoxin type C.
    Schlievert PM; Bettin KM; Watson DW
    Infect Immun; 1979 Nov; 26(2):585-9. PubMed ID: 121110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and characterization of a novel high molecular weight exotoxin produced by red tide phytoplankton, Alexandrium tamarense.
    Yamasaki Y; Katsuo D; Nakayasu S; Salati C; Duan J; Zou Y; Matsuyama Y; Yamaguchi K; Oda T
    J Biochem Mol Toxicol; 2008; 22(6):405-15. PubMed ID: 19111002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.
    Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
    Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of an enterotoxin from Bacteroides fragilis.
    Van Tassell RL; Lyerly DM; Wilkins TD
    Infect Immun; 1992 Apr; 60(4):1343-50. PubMed ID: 1548060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C.
    Smith RJ; Schlievert PM; Himelright IM; Baddour LM
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):245-7. PubMed ID: 7851088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.